| Exchange: |
NCM |
| Last Open: |
1.88 |
| Day Range: |
1.75 - 1.90 |
| Last Close: |
1.78 |
| Change: |
-0.13 (N/A) |
| Volume: |
149,429 |
| Avg Vol (3m): |
110,703 |
| 52wk Range: |
1.28 - 4.50 |
| Market Cap: |
49,900,000 |
| EBITDA: |
N/A |
| Revenue: |
167,000 |
Address:
Prana Biotechnology Ltd.
Level 2 369 Royal Parade
Parkville, VIC 3052
Australia
Web Site:
|
(PRAN) DIVIDEND RATINGS:
| Overall Rating: |
|
| The overall rating is a weighted average of the three other rated categories listed below. It is a general indication of the health of a dividend. Rating last changed:
Never |
|
| Dividend Yield: |
|
| This indicator measures a stock's current dividend yield, and compares it to similar stocks and historical yields. |
| Dividend History: |
|
| The rating for dividend history is determined by looking back at the frequency and amount of historical dividend payments. |
| Div. Increases: |
|
| This indicator measures a stock's history of dividend increases; consistent increases over time will produce a favorable rating.
|
|
HEADLINES FOR (PRAN):
OTHER DRUG MANUFACTURERS - OTHER COMPANIES:
Novo Nordisk A/S (NVO)
Teva Pharmaceutical Industries Limited (TEVA)
Allergan Inc. (AGN)
Valeant Pharmaceuticals International (VRX)
Alexion Pharmaceuticals, Inc. (ALXN)
SEE FULL LIST
|
